A detailed history of Paragon Financial Partners, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Paragon Financial Partners, Inc. holds 4,047 shares of ABT stock, worth $455,854. This represents 0.33% of its overall portfolio holdings.

Number of Shares
4,047
Previous 4,047 -0.0%
Holding current value
$455,854
Previous $459,000 8.5%
% of portfolio
0.33%
Previous 0.38%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $467,549 - $572,488
4,047 New
4,047 $570,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Paragon Financial Partners, Inc. Portfolio

Follow Paragon Financial Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Financial Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Paragon Financial Partners, Inc. with notifications on news.